Abstract
Compatible vial container closure system (CCS) components in combination with a proper capping process are crucial to ensuring reliable performance, maintaining container closure integrity (CCI), and CCS visual acceptance. CCI is essential for parenteral packaging and must be maintained throughout the entire sealed drug product life. To build the most robust CCS performance, many variables, including component selection, fit, function and capping processes must be set according to the actual dimensions of the CCS components used. However, conventional CCS stack-up calculations are based on dimensional engineering data and its tolerance from CCS component drawings without considering the real statistical distributions and their resultant impact on the risk of CCS end performance. CCS dimensional variations may lead to capping failure, resulting in CCS visual defects, CCI failure, and potentially costly destruction of an entire CCS production batch. In this work, we demonstrated a comprehensive approach utilizing real CCS component dimensional data as statistic input for CCS dimension stack up calculations to calculate the actual CCS end performance window and its quantitative failure risk to determine its optimal sealing performance and visual acceptance under different stopper compression percentages. We examined two vial container closure systems as a case study differing by a stopper. Each component was measured and included in comprehensive dimensional stack up calculations. The resulting statistical distributions were used to examine component variability, stack up assemblies at multiple stopper compressions, and how to identify the optimal CCS based on the performance window generated from real data. Using this data-driven approach, we quantitatively identify as little as five percent stopper compression difference can impact the chosen CCS. More importantly, comprehensive dimensional stack up calculations can assist in selecting the best vial CCS, appropriate stopper compression, as well as troubleshoot processing concerns and ensure operation within the optimal CCS performance window.
- Container closure integrity (CCI)
- Container closure system (CCS)
- Dimensional Testing
- Modeling
- Residual seal force (RSF)
- Statistical Distribution
- Received September 3, 2019.
- Accepted January 31, 2020.
- Copyright © 2020, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.